HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

European status of resistance in nosocomial infections.

AbstractBACKGROUND:
Surveillance studies are mandatory to carefully monitor changing trends in Europe.
METHODS:
Surveys on antibiotic resistance conducted in European hospitals were reviewed. Data were obtained from own studies, through searches of Medlines, Pubmed, abstracts and posters presented at meetings, from the World Wide Web and from surveillance studies conducted by the pharmaceutical industry.
RESULTS:
A high prevalence of MRSA was found in most European hospitals, except in northern Europe, and an increasing trend in non-intensive care unit patients was observed. In most European hospitals, the prevalence of infections caused by vancomycin-resistant enterococci remains very low and most outbreaks have occurred in at-risk wards. No major changes of resistance among Enterobacteriaceae were observed. Very few of the major antibiotics are now reliably effective for the treatment of severe nosocomial carbapenem-resistant Acinetobacter infections.
CONCLUSIONS:
Although antimicrobial resistance appears to be increasing all over Europe, it is difficult to accurately estimate the extent of this emerging problem. One of the main reasons for this can be attributed to the fact that the published susceptibility data are difficult to compare due to the different methods used, population bias, and clonal variation. Increasing antimicrobial resistance necessitates a critical appraisal of the remaining antibiotic treatment options.
AuthorsHerman Goossens
JournalChemotherapy (Chemotherapy) Vol. 51 Issue 4 Pg. 177-81 (Jul 2005) ISSN: 0009-3157 [Print] Switzerland
PMID16006764 (Publication Type: Journal Article, Review)
CopyrightCopyright (c) 2005 S. Karger AG, Basel.
Topics
  • Cross Infection (drug therapy, epidemiology)
  • Drug Resistance, Bacterial
  • Europe (epidemiology)
  • Health Surveys
  • Hospitals (statistics & numerical data)
  • Humans
  • Population Surveillance
  • Prevalence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: